2026 Agenda

Global medical tourism remains significantly underpenetrated, with much of the industry still competing for a small pool of price-sensitive self-pay patients instead of building scalable, enterprise-ready systems of care. The larger opportunity lies with multinational employers, global insurers, sovereign funds, brokers, and cross-border healthcare partners seeking structured solutions for complex care and specialty treatments, yet adoption is limited by fragmentation, inconsistent standards, unclear risk models, and lack of integration. This keynote challenges leaders to rethink the market by moving beyond price-driven competition, aligning infrastructure and risk frameworks with enterprise demand, and shifting from transactional referrals to integrated global healthcare systems built for long-term scale.

Global medical tourism is evolving beyond self-pay travel into structured, institutionally driven healthcare mobility led by multinational employers, global insurers, TPAs, and sovereign health buyers seeking cross-border solutions for complex care and specialty treatments. Scaling these models requires infrastructure, transparency, and risk alignment. This session explores how institutional demand, AI integration, longevity medicine, and structured partnerships are reshaping patient mobility, shifting the industry from transactional referrals to coordinated domestic and international Centers of Excellence supported by scalable payment and risk frameworks.

Aclosed-door discussion among CEOs and senior executives on growth, risk, andglobal positioning.

Financial infrastructure is a critical yet often overlooked factor in scaling international patient programs. When payment systems lack clarity, protection, and structure, trust declines and hospitals can lose significant revenue due to hesitation and payer uncertainty. This session explores how structured payment models, transparent pricing, and secure financial frameworks can strengthen confidence among patients and insurers, improve conversion rates, and protect margins while supporting sustainable growth.

Hospitals do not scale alone. Sustainable international growth depends on structured partnerships that generate consistent, high-quality patient volume rather than sporadic referrals. This session explores how to move beyond informal relationships toward performance-based, accountable frameworks that align incentives with insurers, employers, brokers, and referral partners. We will examine how well-designed agreements, employer health programs, and structured distribution models can create predictable expansion while protecting quality and measurable outcomes.

Institutional patient flow is increasingly controlled by insurers, corporate buyers, and self-funded employers who manage healthcare risk and purchasing decisions. As cross-border care becomes more strategic, providers must align with payer expectations around structure, transparency, and financial protection. This session explores how to design viable coverage models, implement risk-sharing frameworks, ensure complication protection, and build the level of trust required to secure long-term partnerships with global insurers and enterprise buyers.

Artificial intelligence is transforming how international patient programs scale, operate, and integrate with payer systems. From initial inquiry to post-treatment coordination, AI enables greater efficiency, personalization, and institutional alignment across borders. This session explores how hospitals can leverage AI-driven lead conversion, predictive analytics, and operational automation to improve acquisition strategies, strengthen multilingual engagement, and enhance coordination between providers and insurers.

Global patient mobility is entering a period of consolidation and strategic realignment, with increasing control shifting to payers, structured networks, technology platforms, and enterprise buyers that influence cross-border care decisions. This session examines how consolidation, payer and employer influence, and digital referral ecosystems are reshaping global healthcare mobility, and how hospitals can position themselves at the center of these evolving networks rather than remaining on the periphery.

Longevity, regenerative medicine, and disease reversal are emerging as a new frontier in global healthcare mobility. As longevity clinics, executive health programs, stem cell therapies, and advanced biologics gain traction, forward-thinking hospitals are building premium programs focused on performance optimization and preventative care. This session explores how to position these advanced therapies for global patients while navigating ethical and regulatory complexity, attracting high-net-worth and employer-sponsored populations, and integrating longevity offerings into structured international and insurance-driven models.

Self-funded employers are increasingly moving beyond traditional network models to directly contract with high-performing domestic and international providers in order to control rising costs in complex surgeries and specialty pharmaceuticals. This executive session explores how employers, brokers, and consultants are leveraging direct contracting, domestic and global Centers of Excellence, bundled pricing with outcome guarantees, and risk-sharing frameworks to reduce total cost of care while protecting employee experience. We will examine practical strategies for specialty pharmacy optimization, incentive alignment, legal and fiduciary considerations, and scalable implementation models that shift organizations from incremental cost containment to structural cost transformation.

Many international patient programs remain reactive, relying on sporadic inquiries and inconsistent referral streams rather than predictable growth. Scaling requires a structured revenue engine that aligns strategy, operations, and measurable performance metrics. This session explores how executive teams can transition from opportunistic lead generation to disciplined revenue modeling, integrated B2C and B2B alignment, and optimized conversion systems that increase lifetime value while strengthening competitive positioning in global markets.

Clinical excellence alone is no longer enough to differentiate in a competitive global market. Leading institutions intentionally design experiences that create emotional connection, confidence, and long-term loyalty among patients and partners. This session explores how hospitals can transform international programs into cohesive brand experiences through structured experience engineering, referral partner design, and consistent delivery that strengthens reputation, enhances retention, and turns patients and partners into long-term ambassadors.